Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Bing Du Xue Bao ; 29(1): 44-50, 2013 Jan.
Article in Chinese | MEDLINE | ID: mdl-23547379

ABSTRACT

Vpr, an auxiliary protein of HIV-1(Human immunodeficiency virus type 1), exerts important functions to promote viral replication and AIDS progression. In this study, we performed a yeast two-hybrid screening assay using human cDNA library to further investigate the molecular mechanism of various functions of Vpr RelB, a key protein in NF-kappaB signaling pathway, was identified as a Vpr interaction protein by co-immunoprecipitation. Further investigations indicated that RelB not only promoted the Vpr-mediated activation of NF-kappaB reporter gene, but also enhanced the transactivation of HIV LTR. Moreover, the results showed that RelB promoted Vpr-induced cell cycle G2/M arrest. Collectively, these results indicated that RelB might interact with Vpr and regulate its transcriptional activation and cell cycle arrest.


Subject(s)
Cell Cycle Checkpoints , Cell Division , G2 Phase , Transcription Factor RelB/physiology , Transcriptional Activation , vpr Gene Products, Human Immunodeficiency Virus/physiology , HIV Long Terminal Repeat , HeLa Cells , Humans , NF-kappa B/genetics
2.
Virol Sin ; 26(6): 403-8, 2011 Dec.
Article in English | MEDLINE | ID: mdl-22160940

ABSTRACT

The ubiquitin-like modifier bISG15 is an antiviral protein found in fetal bovine lung (FBL) cells. Bovine Herpesvirus 1(BHV-1), which is a viral pathogen of cattle, can infect FBL cells and induce cytopathic effects. Real-time PCR assays showed that BHV-1's infection could repress the basal or inducible transcription of bISG15 in FBL cells. It demonstrates that this repression effect depends on BHV-1 viral infection and new protein synthesis. Our previous work showed that bIRF-3 was the key factor in the stimulation of bISG15 in FBL cells, so the effect of BHV-1 viral protein on bIRF-3 activating the promoter of bISG15 was confirmed. The luciferase assay showed the BHV-1 viral protein bICP0 inhibited the activation of bISG15 promoter stimulated by bIRF-3. Taken together, our work suggested that BHV-1 had some molecular mechanism to resist the cellular bISG15's antiviral functions.


Subject(s)
Cattle Diseases/genetics , Down-Regulation , Herpesviridae Infections/veterinary , Herpesvirus 1, Bovine/metabolism , Trans-Activators/metabolism , Transcription, Genetic , Ubiquitin-Protein Ligases/metabolism , Ubiquitin/genetics , Animals , Cattle , Cattle Diseases/metabolism , Cattle Diseases/virology , Cell Line , Gene Expression Regulation, Viral , Herpesviridae Infections/genetics , Herpesviridae Infections/metabolism , Herpesviridae Infections/virology , Herpesvirus 1, Bovine/genetics , Humans , Lung/metabolism , Lung/virology , Trans-Activators/genetics , Ubiquitin/metabolism , Ubiquitin-Protein Ligases/genetics
3.
Virol Sin ; 25(2): 115-22, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20960308

ABSTRACT

Viruses (e.g. Human immunodeficiency virus, Human simplex virus and Prototype foamy virus) are obligate intracellular parasites and therefore depend on the cellular machinery for cellular trafficking. Bovine foamy virus (BFV) is a member of the Spumaretrovirinae subfamily of Retroviruses, however, details of its cellular trafficking remain unknown. In this study, we cloned the BFV gag gene into prokaryotic expression vector pET28a and purified the denaturalized Gag protein. The protein was used to immunize BALB/c mouse to produce antiserum, which could specifically recognize the BFV Gag protein in BFV-infected cells through western blot assay. Additionally, these results demonstrated that both the optimal and suboptimal cleavage of Gag protein occur in BFV-infected cells. Subsequently, the Gag antiserum was used to investigate subcellular localization of BFV. In immunofluorescence microscopy assays, colocalization microtubules (MTs) and assembling viral particles were clearly observed, which implied that BFV may transport along cellular MTs in host cells. Furthermore, MTs-depolymerizing assay indicated MTs were required for the efficient replication of BFV. In conclusion, our study suggests that BFV has evolved the mechanism to hijack the cellular cytoskeleton for its replication.


Subject(s)
Antibodies, Viral , Gene Products, gag/immunology , Spumavirus/physiology , Virus Replication , Animals , Antibodies, Viral/isolation & purification , Cattle , Cells, Cultured , Cloning, Molecular , Fluorescent Antibody Technique, Direct , Gene Expression , Gene Products, gag/genetics , Gene Products, gag/isolation & purification , Mice , Mice, Inbred BALB C , Microtubules/virology , Recombinant Proteins/genetics , Recombinant Proteins/immunology , Recombinant Proteins/isolation & purification
4.
Virol Sin ; 25(2): 137-44, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20960311

ABSTRACT

In order to quantitate the bovine immunodeficiency virus (BIV) infection in vitro, a BIV indicator cell line (BIVL) was established by transfecting baby hamster kidney cells with reporter plasmids containing the firefly luciferase gene driven by a BIV long terminal repeat promoter. The BIV activates promoter activity of the LTR to express luciferase upon infection. BIV infection could therefore by quantified by detection of luciferase activity. Compared to standard assays used to detect BIV infection, the BIVL-based assay is 10 times more sensitive than the the CPE-based assay, and has similar sensitivity with the viral capsid protein Western blot assay. BIV indicator cell line could detect BIV infection specifically. Luciferase activity of BIV infected BIVL cells showed a time dependent manner, and 60 h post infection is the optimal time to detect BIV infection. Luciferase activity of BIVL cells correlates with the BIV capsid protein expression. Moreover, a linear relationship was found between MOI and the activated intensity of luciferase expression. In brief, the BIV indicator cell line is an easy, robust and quantitive method for monitoring BIV infection.


Subject(s)
Genes, Reporter , Immunodeficiency Virus, Bovine/isolation & purification , Luciferases, Firefly/metabolism , Viral Load/methods , Animals , Cell Line , Cricetinae , Luciferases, Firefly/genetics , Plasmids , Sensitivity and Specificity
5.
J Virol Methods ; 163(1): 25-30, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19643140

ABSTRACT

Indicator cell lines are useful biological tools for monitoring virus infection. In order to monitor infection with bovine immunodeficiency virus (BIV) in vitro, an indicator cell line derived from baby hamster kidney cells which contains integrated copies of an enhanced green fluorescent protein gene driven by the BIV long terminal repeat was constructed. The BIV indicator cell line, designated BIVE, can detect BIV infection more easily and effectively than the established method, which involves the observation of cell cytopathic effects. Furthermore, viral titration using an assay based on the indicator cells is 100 times more sensitive than the assay based on cytopathic effect. The finding that BIV can infect the hamster cell line expands the known host range of BIV in vitro. The BIV indicator cell line could also be used for the evaluation of the inhibitory effect of antiviral agents. The fusion inhibition effect of the heptad repeat 2 region of the BIV envelope protein could also be quantified.


Subject(s)
Cattle Diseases/diagnosis , Cell Line , Immunodeficiency Virus, Bovine/isolation & purification , Lentivirus Infections/veterinary , Animals , Antiviral Agents/pharmacology , Cattle , Cattle Diseases/virology , Cricetinae , Flow Cytometry , Green Fluorescent Proteins/genetics , Immunodeficiency Virus, Bovine/drug effects , Lentivirus Infections/diagnosis , Lentivirus Infections/virology , Microscopy, Fluorescence , Sensitivity and Specificity
6.
Arch Virol ; 155(3): 361-6, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20039088

ABSTRACT

Kaposi's sarcoma-associated herpesvirus ORF57 expression is highly responsive to replication and transcription activator (RTA) and interferon regulatory factor 7 (IRF-7). Three RTA response elements (RREs) have been identified in the ORF57 promoter. Here, we show evidence of another functional RRE located between nt 82003 and 82081, which can complement the loss of RTA activation resulting from RRE1 deletion. Repeats of a recombination signal-binding protein Jkappa (RBP-Jkappa) site enhanced RTA activation, which could not be suppressed by IRF-7. Alteration of the distance between the RBP-Jkappa site and RRE2 modulated responsiveness to RTA and IRF-7. These results will help to elucidate the precise regulation of viral gene expression.


Subject(s)
Gene Expression Regulation, Viral , Herpesvirus 8, Human/physiology , Immediate-Early Proteins/metabolism , Interferon Regulatory Factor-7/metabolism , Promoter Regions, Genetic , Response Elements , Trans-Activators/metabolism , Transcription, Genetic , Base Sequence , DNA, Viral/genetics , Herpesvirus 8, Human/genetics , Humans , Molecular Sequence Data , Recombination, Genetic/genetics , Virus Replication
7.
Int J Biochem Cell Biol ; 41(11): 2240-50, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19427400

ABSTRACT

Neurofibromatosis type 1 (NF1) microdeletion is a large genomic deletion that embraces at least 11 continuous genes at human chromosome 17q11.2. To date, most of these genes' functions still remain undefined. In this study, we report an unknown cytokine receptor like molecule (p48.2) that is frequently deleted in patients with type-1 and type-2 NF1 microdeletions in the neurofibromin locus. The cloned gene has 1317 base pair long that encodes a 438aa intracellular protein. The gene was subsequently named p48.2 based on its predicted molecular weight. A typical fibronectin type III (FNIII) domain was identified in p48.2 between Arg(176) and Pro(261) in which a palindromic Arg-Gly-Asp (RGD) repeat plus a putative Trp-Ser-X-Trp-Ser (WSXWS) motif were found at the domain's C-terminus. p48.2 mRNAs were abundant in many tumor cell lines and normal human tissues and up-regulated in some freshly isolated lung cancer and leukemia cells. Interestingly, over-expression of p48.2 in human embryo kidney 293T cells could significantly cause G0/G1 arrest and prevented S phase entry. In contrast, repressing endogenous p48.2 gene expression by specific siRNA markedly reduced G0/G1 population. Importantly, over-expression of p48.2 could significantly up-regulate rather than down-regulate cyclin D1 and cyclin D3 expressions. We further showed that the induction of cyclin D1 expression was directly due to the activation of signal transducers and activators of transcription 3 (STAT3), but was independent of RAS/mitogen-activated protein kinase (RAS/MAPK) signaling pathway. Thus, p48.2 may represent a novel type of intracellular protein functioning as a negative regulator at the G0/G1 phase.


Subject(s)
Cell Cycle Proteins/genetics , Cell Cycle , Intracellular Space/metabolism , Receptors, Cytokine/genetics , Amino Acid Sequence , Animals , Base Sequence , Cell Cycle/genetics , Cell Cycle Proteins/chemistry , Cell Cycle Proteins/metabolism , Cell Line , Cloning, Molecular , Computational Biology , Cyclin D1/genetics , Cyclin D1/metabolism , Cyclin D3/genetics , Cyclin D3/metabolism , Down-Regulation/genetics , G1 Phase , Gene Expression Profiling , Gene Expression Regulation , Genome, Human/genetics , Humans , Mice , Molecular Sequence Data , Promoter Regions, Genetic/genetics , RNA, Small Interfering , Receptors, Cytokine/chemistry , Receptors, Cytokine/metabolism , Resting Phase, Cell Cycle , STAT3 Transcription Factor/metabolism , Sequence Homology, Amino Acid , Signal Transduction
8.
Chin Med J (Engl) ; 122(23): 2874-9, 2009 Dec 05.
Article in English | MEDLINE | ID: mdl-20092794

ABSTRACT

BACKGROUND: The CRF07_BC recombinant strain has been one of the most predominantly circulated HIV-1 strains in China, it is therefore necessary and urgent to develop a relevant animal model to evaluate candidate vaccines targeting HIV-1 CRF07_BC. A highly replication-competent simian/human immunodeficiency viruses (SHIV) construct containing the Chinese CRF07_BC HIV-1 env gene with the ability to infect Chinese rhesus monkeys would serve as an important tool in the development of HIV vaccines. The aim of this study was to examine whether SHIV XJDC6431 with the env fragment from a Chinese HIV-1 isolate virus could infect the human and monkey peripheral blood mononuclear cell (PBMC), establish infection in Chinese rhesus macaque. METHODS: A SHIV strain was constructed by replacing the rev/env genes of SHIV KB9 with the corresponding fragment derived from the HIV-1 CRF07_BC strain. The infectious activity of the SHIV clones was determined in vitro in PBMCs from both non-human primate animals and humans. Finally, one Chinese rhesus macaques (Macaca mulatta) was infected with one SHIV via intravenous infusion. RESULTS: One SHIV clone designated as SHIV XJDC6431, was generated that could infect macaque and human PBMC. The virus produced from this clone also efficiently infected the CCR5-expressing GHOST cell lines, indicating that it uses CCR5 as its coreceptor. Finally, the virus was intravenously inoculated into one Chinese rhesus macaque. Eventually, the animal became infected as shown by the occurrence of viremia within 3 of infection. The viral load reached 105 copies of viral RNA per ml of plasma during the acute phase of infection and lasted for 10 weeks post infection. CONCLUSIONS: We conclude that SHIV XJDC6431 is an R5-tropic chimeric virus, which can establish infection not only in vitro but also in vivo in the Chinese rhesus macaque. Although the animal inoculated with SHIV XJDC6431 became infected without developing a pathologic phenotype, the virus efficiently replicated with a persistent level of viral load in the plasma. This suggested that the SHIV could be used as a tool to test candidate AIDS vaccines targeting the Chinese HIV-1 CRF_07BC recombinant strain.


Subject(s)
Genes, env , HIV-1/genetics , Simian Immunodeficiency Virus/genetics , Animals , Chimera , HIV-1/physiology , Humans , Macaca mulatta , Proviruses/genetics , Receptors, CCR5/physiology , Simian Immunodeficiency Virus/physiology
9.
Acta Pharmacol Sin ; 28(7): 994-1000, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17588335

ABSTRACT

AIM: To determine the infectivity and replication strategy of bovine foamy virus (BFV) in different cultured cells using the BFV indicator cell line (BICL) system. METHODS: BFV infection was induced by the co-culture method or the transient transfection of the infectious BFV plasmid [pCMV (cytomegalovirus) - BFV] clone. The infectivity of BFV was monitored by the percentage of green fluorescent protein-positive cells in the BICL. The effect of reverse transcriptase inhibitor zidovudine (AZT) on BFV replication was also evaluated in the BICL. RESULTS: The titer of BFV in fetal bovine lung cells was 4-5-folds more than that in either 293T or HeLa (Cells from Henrietta lacks) cells using the co-culture method, and in the meantime was significantly higher than that produced by the infectious clone pCMV-BFV in the same cells. AZT had only a minor effect on viral titers when added to cells prior to the virus infection. In contrast, viral titers reduced sharply to the level of the negative control when the virus was produced from cells in the presence of AZT. CONCLUSIONS: BICL can be used for the titration of the BFV viral infection in non-cytopathic condition. In addition, we provide important evidence to show that reverse transcription is essential for BFV replication at a late step of viral infection.


Subject(s)
Retroviridae Infections/metabolism , Spumavirus/metabolism , Spumavirus/pathogenicity , Animals , Biological Assay/methods , Cattle , Cell Line , Green Fluorescent Proteins/genetics , Green Fluorescent Proteins/metabolism , Humans , Retroviridae Infections/diagnosis , Reverse Transcriptase Inhibitors/pharmacology , Spumavirus/genetics , Virus Replication/drug effects , Zidovudine/pharmacology
10.
World J Gastroenterol ; 11(17): 2609-15, 2005 May 07.
Article in English | MEDLINE | ID: mdl-15849820

ABSTRACT

AIM: To explore the possibility of the replacement of the gag gene between human immunodeficiency virus and bovine immunodeficiency virus, to achieve chimeric virions, and thereby gain a new kind of AIDS vaccine based on BHIV chimeric viruses. METHODS: A series of chimeric BHIV proviral DNAs differing in the replacement regions in gag gene were constructed, and then were transfected into 293T cells. The expression of chimeric viral genes was detected at the RNA and protein level. The supernatant of 293T cell was ultra centrifuged to detect the probable chimeric virion. Once the chimeric virion was detected, its biological activities were also assayed by infecting HIV-sensitive MT4 cells. RESULTS: Four chimeric BHIV proviral DNAs were constructed. Genes in chimeric viruses expressed correctly in transfected 293T cells. All four constructs assembled chimeric virions with different degrees of efficiency. These virions had complete structures common to retroviruses and packaged genomic RNAs, but the cleavages of the precursor Gag proteins were abnormal to some extent. Three of these virions tested could attach and enter into MT4 cells, and one of them could complete the course of reverse transcription. Yet none of them could replicate in MT4 cells. CONCLUSION: The replacement of partial gag gene of HIV with BIV gag gene is feasible. Genes in chimeric BHIVs are accurately expressed, and virions are assembled. These chimeric BHIVs (proviral DNA together with virus particles) have the potential to become a new kind of HIV/AIDS vaccine.


Subject(s)
AIDS Vaccines/genetics , Acquired Immunodeficiency Syndrome/prevention & control , Genes, gag/genetics , HIV-1/genetics , Immunodeficiency Virus, Bovine/genetics , Animals , Cattle , Cells, Cultured , Humans , Recombinant Fusion Proteins/genetics , Transfection
11.
Article in Chinese | MEDLINE | ID: mdl-12869996

ABSTRACT

OBJECTIVE: Chimeric human/bovine immunodeficiency virus (HBIV) cDNA was constructed by replacing HIV tat and LTR with bovine immunodeficiency virus (BIV) tat and LTR to study the activity of BIV tat and LTR in the chimerae. METHODS: The target fragments of BIV tat, LTR and HIV gag, pol, env were respectively amplified by using PCR and sequentially inserted into pBluescript SK(+) vector. The chimeric clone was transfected into human MT4 cells. The transcript and gene expression of the HBIV chimeric virus were detected by using RT-PCR and a reverse transcriptase assay, respectively. RESULTS: BIV tat mRNA and HIV gag mRNA were detected. The reverse transcriptase activity of the chimeric virus was analyzed in the fluctuation curve. CONCLUSIONS: In chimeric HBIV cDNA transfected MT?4 cells, BIV tat and HIV gag were transcripted. The reverse transcriptase of the chimeric virus had biological activity. These data suggest that in MT4 cells, BIV LTR had promoter activity and BIV tat had the function of transactivation in the chimeric virus. The study of the chimeric virus with infectivity is in progress.


Subject(s)
DNA, Viral/genetics , Genes, tat/genetics , HIV-1/genetics , Immunodeficiency Virus, Bovine/genetics , Recombinant Fusion Proteins/genetics , AIDS Vaccines , Animals , Cattle , Cloning, Molecular , DNA, Complementary/genetics , Genes, gag/genetics , Genes, pol/genetics , Humans , Recombinant Fusion Proteins/metabolism , Transcription, Genetic , Transcriptional Activation , Transfection , Virus Replication
SELECTION OF CITATIONS
SEARCH DETAIL
...